[Comparative studies on the bioequivalency of digoxin (Lanoxin) and of beta-methyldigoxin (Lanitop) in patients with cardiac insufficiency]. 1977

H Otten, and J Gerloff, and G Bodem

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

H Otten, and J Gerloff, and G Bodem
August 1974, Polski tygodnik lekarski (Warsaw, Poland : 1960),
H Otten, and J Gerloff, and G Bodem
January 1975, Zeitschrift fur Kardiologie,
H Otten, and J Gerloff, and G Bodem
January 1976, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
H Otten, and J Gerloff, and G Bodem
January 1974, Padiatrie und Padologie,
H Otten, and J Gerloff, and G Bodem
April 1977, Kardiologiia,
H Otten, and J Gerloff, and G Bodem
January 1973, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
H Otten, and J Gerloff, and G Bodem
June 1975, European journal of clinical pharmacology,
H Otten, and J Gerloff, and G Bodem
August 1975, Wiener medizinische Wochenschrift (1946),
H Otten, and J Gerloff, and G Bodem
September 1980, La Clinica terapeutica,
H Otten, and J Gerloff, and G Bodem
December 1975, Schweizerische medizinische Wochenschrift,
Copied contents to your clipboard!